Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases

Genes Chromosomes and Cancer

Volumn 25, Issue 3, 1999, Pages 290-300

  Taetle, Raymond ^a,c   Aickin, Mikel ^a   Yang, Jin Ming ^a   Panda, Lita ^a   Emerson, Julia ^a   Roe, Denise ^a   Adair, Lawrence ^a   Thompson, Floyd ^a   Liu, Yun ^a   Wisner, Lee ^a   Davis, John R ^a   Trent, Jeffrey ^b   Alberts, David S ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME LOSS; CYTOGENETICS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; PRIORITY JOURNAL;

EID: 0033062158     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199907)25:3<290::AID-GCC12>3.0.CO;2-G     Document Type: Article

References (46)

1. Aickin M, Gensler H. 1996. An improvement in reporting results adjusted for multiple testing. Am J Public Health 86:726-728.
2. Bello MJ, Rev JA. 1990. Chromosome aberrations in metastatic ovarian cancer: relationship with abnormalities in primary tumors. Int J Cancer 45:50-54.
3. Brooks DJ, Woodward S, Thompson FH, Dos Santos B, Russell M, Yang J-M, Guan X-Y, Trent J, Alberts DS, Taetle R. 1996. Expression of the Zn-finger gene EVI-1 in ovarian, other cancers. Br J Cancer 74:1518-1525.
4. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM. 1996. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14:457-460.
5. FIGO: International Federation of Gynecology, Obstetrics. 1971. Classification, staging of malignant tumors in the female pelvis. Acta Obstet Gynaecol Scand 50:1-7.
6. Gallion HH, Powell DE, Smith LW, Morrow JK, Martin AW, van Nagell JR, Donaldson ES. 1990. Chromosome abnormalities in human epithelial ovarian malignancies. Gynecol Oncol 38:473-477.
7. Holm S. 1979. A simple sequentially rejective multiple test procedure. Scand J Stat 6:65-70.
8. Iwabuchi H, Sakamoto M, Sakunaga H, Ma Y, Carcangiu M, Pinkel D, Yang-Feng T, Gray J. 1995. Genetic analysis of benign, low-grade, high-grade ovarian tumors. Cancer Res 55:6172-6180.
9. Jenkins RB, Bartlet D Jr, Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G, Hartmann L. 1993. Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet 71:76-86.
10. Johansson B, Mertens F, Mitelman F. 1996. Primary vs secondary neoplasia-associated chromosomal abnormalities-balanced rearrangements vs. genomic imbalances? Genes Chromosomes Cancer 16:155-163.
11. Kalbfleisch JD, Prentice RL, Russ L. 1980. The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons.
12. McGill JR, Beitzel BF, Nielsen JL, Walsh JT, Drabek SM, Meador RJ, Von Hoff DD. 1993. Double minutes are frequently found in ovarian carcinomas. Cancer Genet Cytogenet 71:125-131.
13. Mertens F, Johansson B, Hoglund M, Mitelman F. 1997. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 57:2765-2780.
14. Mertens F, Johansson B, Mitelman F. 1994. Isochromosomes in neoplasia. Genes Chromosomes Cancer 10:221-230.
15. Mitelman F, Johansson B, Mandahl N, Mertens F. 1997a. Clinical significance of cytogenetic findings in solid tumors. Cancer Genet Cytogenet 95:1-8.
16. Mitelman F, Mertens F, Johansson B. 1997b. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15:417-474.
17. Nichols J, Nimer SD. 1992. Transcription factors, translocations, and leukemia. Blood 80:2953-2963.
18. Nowell PC. 1994. Cytogenetic approaches to human cancer genes. FASEB J 8:408-413.
19. Parza NZ, Taetle R, Nelson M, Adair T, Alberts D, Leong S, Salmon S, Krizman D, Thompson FG, Trent J. 1994. Chromosome instability in 75 untreated ovarian cancer patients. Cancer Genet Cytogenet 73:33-33.
20. Pedersen-Bjergaard J, Rowley JD. 1994. The balanced, the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways, may contribute differently to malignant transformation. Blood 83:2780-2786.
21. Pejovic T, Heim S, Mandahl N, Bladetorp B, Elmfors B, Floderus U-M, Furgyik S, Helm G, Himmelman A, Willen H, Mitelman F. 1992a. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer 4:58-68.
22. Pejovic T, Himmelman A, Heim S, Mandahl N, Floderus U-M, Furgyik S, Elmfors B, Helm G, Willen H, Mitelman F. 1992b. Prognostic impact of chromosome aberrations in ovarian cancer. Br J Cancer 65:282-286.
23. Pejovic T, Iosif C, Mitelman F, Heim S. 1996. Karyotypic characteristics of borderline malignant tumors of the ovary: trisomy 12, trisomy 7, and r(1) as nonrandom features. Cancer Genet Cytogenet 92:95-98.
24. Peto R, Pike M, Armitage P, Breslow N, Cox DR, Howard WV, Manetl N, McPherson K, Peto J, Smith P. 1976. Design, analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 34:585-612.
25. Roberts CG, Tettersall M. 1990. Cytogenetic study of solid ovarian tumors. Cancer Genet Cytogenet 48:243-253.
26. Rodriguez, E, Sreekantaiah C, Chaganti RSK. 1994. Genetic changes in epithelial solid neoplasia. Cancer Res 54:3398-3406.
27. Russell P, Farnsworth A. 1997. Surgical Pathology of the Ovaries. New York: Churchill Livingstone.
28. Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Sing Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. 1996. Multicolor spectral karyotyping of human chromosomes. Science 273:494-497.
29. Serov S F, Scully RE, Sobin LH. 1973. International Histological Classification of Tumors, no. 9. Geneva: World Health Organization.
30. Sheer D, Squire J. 1996. Clinical applications of genetic rearrangements in cancer. Semin Cancer Biol 7:25-32.
31. Sorensen P, Triche T. 1996. Gene fusions encoding chimaeric transcription factors in solid tumours. Semin Cancer Biol 7:3-14.
32. Standing Committee on Human Cytogenetic Nomenclature. 1985. ISCN 1985: An International System for Human Cytogenetic Nomenclature. Basel; New York: Karger.
33. Taetle R, Aickin M, Panda L, Emerson J, Roe D, Thompson F, Davis J. Trent J, Alberts D. 1999. Chromosome abnormalities in ovarian adenocarcinoma. II. Prognostic impact of non-random chromosome abnormalities in 244 cases. Genes Chromosomes Cancer 25:46-52.
34. Testa JR. 1997. Chromosome translocations in human cancer. Cell Growth Differ 1:97-101.
35. Thompson F, Emerson J, Dalton W, Yang J-M, McGee D, Villar H, Knox S, Massey K, Weinstein R, Bhattacharyya A, Trent J. 1993. Clonal chromosome abnormalities in human breast carcinomas. I. Twenty-eight cases with primary disease. Genes Chromosomes Cancer 7:185-193.
36. Thompson FH, Emerson J, Alberts D, Liu Y, Guan X-Y, Burgess A, Fox S, Taetle R, Weinstein R, Makar R, Powell D, Trent J. 1994a. Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 73:33-45.
37. Thompson FH, Liu Y, Emerson JC, Weinstein R, Makar R, Trent JM, Taetle R, Alberts DS. 1994b. Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma. Genes Chromosomes Cancer 10:262-266.
38. Thompson FH, Emerson J, Olson S, Weinstein R, Leavitt SA, Leong SPL, Emerson S, Trent JM, Nelson MA, Salmon SE, Taetle R. 1995. Cytogenetics of 158 patients with regional or disseminated melanoma: subset analysis of near diploid, simple karyotypes. Cancer Genet Cytogenet 83:93-104.
39. Thompson FH, Nelson MA, Trent JM, Guan X-Y, Liu Y, Yang J-M, Emerson J, Adair L, Wymer J, Balfour C, Massey K, Weinstein R, Alberts DS, Taetle R. 1996. Amplification of 19q13.1-q13.2 sequences in ovarian cancer: G-band, FISH, and molecular studies. Cancer Genet Cytogenet 87:55-62.
40. Thompson FH, Taetle R, Trent JM, Liu Y, Massey-Brown K, Scott KM, Weinstein RS, Emerson JC, Alberts DS, Nelson MA. 1997. Band 1p36 abnormalities, t(1:17) in ovarian carcinoma. Cancer Genet Cytogenet 96:106-110.
41. van der Riet-Fox MF, Retief AE, van Niekerk WA. 1979. Chromosome changes in 17 human neoplasms studied with banding. Cancer 44:2108-2119.
42. Veldman T, Vignon C, Schrock E, Rowley JD, Ried T. 1997. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 15:406-410.
43. Wake N, Hreshchyshyn MM, Piver S, Matsui S, Sandberg AA. 1980. Specific cytogenetic changes in ovarian cancer involving chromosomes 6, 14. Cancer Res 40:4512-4518.
44. Whang-Peng J, Knutsen T, Douglass EC, Chu E, Ozols RF, Hogan WM. Young RC. 1984. Cytogenetic studies in ovarian cancer. Cancer Genet Cytogenet 11:91-106.
45. Young RC, Perez CA, Hoskins WJ. 1993. Cancer of the Ovary. In DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles, practice of oncology, 4th ed. Philadelphia: J.B. Lippincott, p 1226-1263.
46. Zhang L, Zhou W, Velculescu V, Kern S, Hruban R, Hamilton S, Vogelstein B, Kinzler K. 1997. Gene expression profiles in normal cancer cells. Science 276:1268-1272.